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Purpose. To demonstrate the transdermal iontophoretic delivery of a small (12.4 kDa) protein across
intact skin.
Materials and Methods. The iontophoretic transport of Cytochrome c (Cyt c) across porcine ear skin in
vitro was investigated and quantified by HPLC. The effect of protein concentration (0.35 and 0.7 mM),
current density (0.15, 0.3 or 0.5 mA.cmj2 applied for 8 h) and competing ions was evaluated. Co-
iontophoresis of acetaminophen was employed to quantify the respective contributions of
electromigration (EM) and electroosmosis (EO).
Results. The data confirmed the transdermal iontophoretic delivery of intact Cyt c. Electromigration was
the principal transport mechanism, accounting for õ90% of delivery; correlation between EM flux and
electrophoretic mobility was consistent with earlier results using small molecules. Modest EO inhibition
was observed at 0.5 mA.cmj2. Cumulative permeation at 0.3 and 0.5 mA.cmj2 was significantly greater
than that at 0.15 mA.cmj2; fluxes using 0.35 and 0.7 mM Cyt c in the absence of competing ions
(Jtot = 182.8 T 56.8 and 265.2 T 149.1 mg.cm
j2.hj1, respectively) were statistically equivalent. Formulation
in PBS (pH 8.2) confirmed the impact of competing charge carriers; inclusion of õ170 mM Na+ resulted
in a 3.9-fold decrease in total flux.
Conclusions. Significant amounts (õ0.9 mg.cmj2 over 8 h) of Cyt c were delivered non-invasively across
intact skin by transdermal electrotransport.
KEY WORDS: cytochrome c; electromigration; iontophoresis; protein delivery; skin permeation.
INTRODUCTION
The physicochemical properties of peptides and pro-
teins, namely, high molecular weight, charge and hydro-
philicity, severely restrict their uptake by the lipid-rich
stratum corneum and limit passive diffusion through the
intercellular lipid matrix. However, charge and hydrophilicity
facilitate peptide electrotransport through the skin, via
primarily aqueous transport pathways, by transdermal ionto-
phoresis (1): a non-invasive technology that uses a mild
electric current to increase the mobility of charged molecules
across the skin (2,3).
Although there are reports of the iontophoretic en-
hancement of different peptide hormones with molecular
weights (MW) in the 1–6 kDa range including luteinising
hormone releasing hormone (4,5), calcitonin (6,7), growth
hormone releasing hormone (8), human parathyroid hor-
mone (9) and insulin (10,11), the effect of molecular size and
protein structure on iontophoretic transport has not been
well characterized. For a series of fluorescently-labeled poly-
L-lysines (FITC-PLLs) ranging in MW from 4 to 26 kDa,
iontophoresis enhanced the penetration of the 4 kDa analog
but did not have any effect on the transport of the larger 26
kDa FITC-PLL (12). The transdermal iontophoretic flux of
an unidentified cationic protein (BProtein X^) with molecular
weight of õ12 kDa at an applied current density of 0.1
mA.cmj2 (concentration not given, assayed by radioactive-
labelling), was measured to be õ15 mg.cmj2.hj1 (13). It was
subsequently reported that BProtein X^ was in fact
Cytochrome c (14). Comparison of the normalized ion-
tophoretic fluxes of a series of negatively charged
compounds across hairless mouse skin (HMS) in vitro as a
function of MW suggested that electrotransport decreased
with increasing molecular size (15). It has also been proposed
that large, bulky ions will only carry a small fraction of the
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charge passing across the skin and hence can only be
transported by electroosmosis; thus, as cation MW
increases, there will be a transition in the dominant
iontophoretic transport mechanism from electromigration
(EM) to electro-osmosis (EO) (16).
Our recent work has demonstrated that the ratio of
charge to MW, which determines electric mobility, is a key
parameter in governing iontophoretic peptide transport
rates (17). A comparison of lysine and H-Lys-Lys-OH
transport revealed that the 2-fold increase in molecular weight
(149 and 274 Da) was compensated by doubling the charge
(Jtot = 225 T 48 and 218 T 40 nmol. cm
j2.hj1, respectively); in
contrast, H-His-Lys-OH, with approximately the same
molecular weight as H-Lys-Lys-OH but unit charge (at pH 7.4),
had a significantly lower flux (107T 29 nmol.cmj2.hj1). For
dipeptides of a given MW, e.g., H-Tyr-D-Arg-OH (MW = 337
Da, +1) and H-Tyr-D-Arg-NH2 (MW = 336 Da, +2), the
increment in charge led to a significant difference in total flux
(150 T 26 and 237 T 35 nmol.cmj2.hj1, respectively).
Furthermore, we have also shown that there is a correlation
between EM flux across skin and electrophoretic mobility
measured by capillary zone electrophoresis (CZE):
increasing mobility resulted in increased EM flux for a
series of small molecules that did not interact with the skin
transport pathway (18). Thus, it seemed appropriate to
investigate whether the principle of using molecular charge to
facilitate electrotransport by compensating for molecular
weight, and hence increasing electric mobility, could be
extended to proteins. If this were the case, it would obviously
increase the range of molecules that could be considered as
candidates for non-invasive iontophoretic administration across
the skin.
Horse heart cytochrome c (Cyt c, Fig. 1) was chosen as a
model protein (19). It has a compact globular structure
consisting of a single polypeptide chain, which houses a central
heme group. It has a MW of õ12.4 kDa, an isoelectric point of
10.2, (the protein contains a total of 21 amino acids with
positively charged side-chains (Arg and Lys), 12 amino acids
with negatively charged side-chains (Asp and Glu), and three
His residues. The aim of the present work was (1) to evaluate
the feasibility of delivering intact Cyt c across the skin by
transdermal iontophoresis, (2) to demonstrate that electro-
migration and not electroosmosis was the key transport
mechanism and (3) to investigate the effect of experimental
variables including protein concentration, applied current
density, and the presence of competing charge carriers, on
iontophoretic transport rates in order to establish whether
these factors, which govern small molecule delivery, affected
macromolecular transport in the same way.
MATERIALS AND METHODS
Materials
Horse heart Cyt c (MW õ12.4 kDa; charge õ+9 at pH 8.2),
acetaminophen (ACE), sodium chloride, di-sodium hydrogen
phosphate, potassium dihydrogen phosphate, trifluoroacetic
acid (TFA), and citric acid were all purchased from Fluka
(Saint Quentin Fallavier, France). Silver wire and silver
chloride used for the fabrication of electrodes and acetonitrile
(Acetonitrile Chromasolv\ HPLC, gradient grade) were pur-
chased from Sigma-Aldrich (St. Quentin Fallavier, France).
Silicon tubing (3.2 mm ID, 6 mm OD, 1 mm wall) for collecting
samples and PVC tubing (3 mm ID, 5 mm OD, 1 mm wall) used
to prepare salt bridge assemblies were obtained from Fisher
Bioblock Scientific S.A. (Illkirch, France). All solutions were
prepared using deionised water (resistivity > 18 MW.cm). All
other chemicals were at least of analytical grade.
Protein Stability
Solution Stability. The stability of Cyt c in solution as a
function of temperature was investigated by periodic sampling
of solutions (10 and 100 mg.mlj1 in phosphate buffered saline
pH 7.4 (PBS); 16.8 mM Na2HPO4 / 1.4 mM KH2PO4 / 136.9 mM
NaCl) in order to ensure the integrity of the protein in the
putative receptor phase for a period of 48 h. Cyt c formulations
were stored at 5 and 25-C. Samples were assayed after 8, 24 and
48 h and were run twice.
Electrical Stability. The impact of electrical current on
the stability of Cyt c solutions was evaluated prior to the
iontophoretic permeation studies. 5 ml of unbuffered protein
solution (8.7 mg.mlj1 (0.7 mM), typical concentration for the
permeation studies, pH 8.2) was subjected to a current
density of 0.5 mA.cmj2 using salt bridges (20). Samples
were collected and analysed every hour for a period of 8 h.
Experiments were performed in triplicate.
Stability in the Presence of Skin. The influence of porcine
ear skin on Cyt c stability in solution was assessed by preparing
(a) 1 mg.mlj1 Cyt c in 10 mM NaCl (pH 8.2) and (b) 100 mg.mlj1
Cyt c in PBS at pH 7.4. Dermatomed epidermal and dermal skin
surfaces were placed in contact with solutions (a) and (b),
respectively during 8 h. Samples were evaluated separately and
experiments were performed in triplicate.
Iontophoretic Permeation
Protocol. Porcine ears were obtained from a local abattoir
(STAC, Chambery, France). The skin was excised (thickness
750 mm) with an electro-dermatome (Zimmer, Etupes, France),
wrapped in Parafilm PM and stored at j20-C for a maximum
period of 2 months. Dermatomed skin was clamped in three-
compartment vertical flow-through diffusion cells (area 0.85 cm2).
The anode (containing PBS buffer at pH 7.4) was isolated from
the donor solution via a salt bridge (SB) assembly (3% agarose
in 0.1 M NaCl) to minimize the effect of competing ions (20).
After a 40 min equilibration period with PBS, 1 ml of unbuffered
peptide solution containing Cyt c (0.7 mM, pH 8.2) and ACE
(15 mM) was placed in the donor compartment. ACE was
used to report on the electroosmotic solvent flow (20). The
cathodal and receptor compartments were filled with 1 and 6 ml
of PBS (pH 7.4), respectively. A syringe pump (model SP220IZ,
WPI, Sarasota, FL) generated a continuous flow of buffer
solution (1 ml.hj1) through the receiver compartment, and
samples were collected hourly from the second hour onwards.
Constant current densities of 0.15, 0.3 and 0.5 mA.cmj2 were
applied for 8 h via Ag/AgCl electrodes connected to a power
supply (Kepco\ APH 1000M, Flushing, NY).
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Fig. 1. Three-dimensional structure of horse heart Cytochrome c (Cyt c; 12.4 kDa, +9 at pH 8.2); the compact globular structure of the protein
is readily discernable (the heme group is shown in green). a and c present different views of the solvent accessible (Connolly) surface showing
the electrostatic potential distribution across the molecular surface (red and blue colours represent regions of high positive and negative
charge density, respectively). Distinct areas of positive and negative charge density can be clearly seen in (a); a more homogenous surface
charge distribution is shown in (c). The corresponding views of the protein backbone, tertiary structure and the distribution of positively (Arg
and Lys; cyan) and negatively (Asp and Glu; yellow) charged amino acid residues are shown in (b) and (d). The charged amino acids are
predominantly located on the protein surface; the presence of negative charge density may inhibit electrostatic interactions between Lys or
Arg residues and negative charge sites in the transport pathway (see BDiscussion’’); thus, reducing the effect of Cyt c passage on skin
permselectivity. The 1hrc pdb file (Author Y Luo and G.D. Brayer (19) was downloaded from http://www.rcsb.org. Molecular modelling and
graphics were done using SYBYL\ 7.1 (Tripos Inc., 1699 South Hanley Rd., St. Louis, Missouri, 63144, USA).
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Effect of Concentration. This was investigated in a
separate study, where the donor compartment contained a
solution comprising 0.35 mM Cyt c and 15 mM ACE. All other
aspects of the protocol were the same as those outlined above.
Effect of Competing Ions. Cyt c solution (0.7 mM) was
prepared using PBS buffer at õpH 8.2 in order to investigate
the effect of competing cations. These formulations contained
õ170 mM Na+; transport experiments were conducted at a
current density of 0.5 mA.cmj2.
The permeation experiments were performed in at least
quadruplicate.
HPLC Analysis
A P680A LPG-4 pump equipped with an ASI-100 auto
sampler and a UV-Vis detector (UVD 170/340-U) (Dionex,
Voisins LeBretonneux, France) was used to quantify Cyt c.
Isocratic separation was performed using a 150 mm 4.6 mm
base stable (from pH 2.0–10) column packed with 5 mm C4
silica reversed-phase particles (Phenomenex, Le Pecq, France).
The flow-rate and the injection volume were 1.0 ml.minj1 and
10–100 ml, respectively; the column temperature was kept at
30-C using a thermostat (TCC-100, Dionex GmbH, Germany).
The mobile phase consisted of 66.0% of the aqueous
component (0.1% TFA (v/v) in water pH 2.0) and 34.0% of
the organic phase (0.1% TFA (v/v) in a 90:10 mixture of MeCN:
water) (adapted from (21)). The column was equilibrated for at
least 1 h. All solvents were filtered (0.45 mm pore size nylon
membrane filter) and degassed prior to use. The UV absorbance at
400 nm was used to detect the protein. The limit of quantification
(LOQ) and detection (LOD) were 190.0 and 62.7 ng, respectively.
ACE was assayed separately using a Lichrospher\ 100 RP-8 5 mm
reversed-phase column (125 4 mm; Lichrocart) with pre-filter.
The mobile phase comprised 88% citrate buffer 40 mM (pH = 3.0)
and 12% MeCN. Fresh buffer solution was prepared daily. The
flow rate and the injection volume were 1.0 ml.minj1 and 10–
100 ml, respectively. All the samples were diluted (1:20) prior to
the analysis. ACE was detected by its UV absorbance at 243 nm.
The LOQ and LOD were 8.9 and 2.9 ng, respectively.
The amount of Cyt c retained in the skin samples during the
iontophoretic permeation experiments at 0.3 and 0.5 mA.cmj2
was estimated by skin extraction using the HPLC mobile phase
as the extraction medium. Five and ten ml of mobile phase
comprising 66.0% of the aqueous phase (0.1% TFA (v/v) in
water pH 2.0) and 34.0% of the organic phase (0.1% TFA (v/v)
in a 90:10 mixture of MeCN: water 90:10) were used for the
samples from the experiments at 0.3 and 0.5 mA.cmj2,
respectively. The skin samples were cut and immersed in the
solvent for 4 h under constant stirring at ambient temperature.
The samples were analysed using HPLC and the experiments
were performed in at least triplicate.
Theory
Estimation of EM and EO Contributions
The total iontophoretic flux (Jtot, Cyt c) of Cyt c, assuming
negligible passive diffusion, is the sum of the fluxes dues to
electromigration (JEM, Cyt c) and electroosmosis (JEO, Cyt c)
and is given by Eq. 1 (22):
Jtot;Cytc ¼ JEM;Cytc þ JEO;Cytc
¼ id
F
 uCytc
Pi
1
ziuici
þ VW
0
B
B
B
@
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A
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JEM,Cyt c is related to the current density (id), by
Faraday_s constant (F) and is proportional to uCyt c and
cCyt c, the mobility and concentration, respectively of the
protein in the membrane; zi, ui, and ci refer to the
corresponding values for the other charge carriers in the system.
The EO contribution, JEO, Cyt c, is proportional to the volume
flow induced by the applied potential gradient and is the
product of the solvent permeability coefficient (VW) and the
protein concentration, cCyt c; the former can be estimated from
Eq. 2 (20):
VW ¼ JACE
cACE
ð2Þ
where JACE is the ACE flux and cACE is its concentration in
the donor compartment.
Inhibition Factor
For each experiment, an inhibition factor (IF) was
calculated using the following equation:
IF ¼ VW;control
VW;Cytc
ð3Þ
where Vw,control is the solvent permeability coefficient calcu-
lated during 8 h of iontophoresis in the absence of protein,
and Vw,Cyt c is the corresponding value when Cyt c was
simultaneously iontophoresed.
Statistical Analysis
Data were expressed as mean T S.D. Outliers, deter-
mined using the Grubbs test (23), were discarded. The results
were evaluated statistically using analysis of variance
(ANOVA); Student_s t-test was used to compare two data
sets. The level of significance was fixed at p < 0.05.
RESULTS
Cytochrome c Stability
HPLC analysis confirmed that Cyt c response (retention
time, peak width, and symmetry) was unaffected by current
application (0.5 mA.cmj2) for 8 h. Furthermore, Cyt c was also
stable in the presence of both epidermal and dermal skin
samples (Student_s t-test, p < 0.05). Similarly, the solution stability
experiments carried out at different temperatures also showed
that the protein was unchanged; statistical tests did not show any
significant difference between the samples stored for 48 h at 5
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and 25-C. These results suggested that Cyt c would be stable
under the conditions to be used for the permeation experiments.
Iontophoretic Delivery
In the first series of Cyt c transport experiments, the
impact of increasing current density from 0.15 to 0.5 mA.cmj2
was tested using a protein concentration of 0.7 mM. The
cumulative amount permeated and the iontophoretic flux at
0.15, 0.3 and 0.5 mA.cmj2 are shown in Fig. 2. The measured
steady-state fluxes were 90.91 T 45.07, 157.77 T 140.13, and
265.15 T 149.05 mg.cmj2.hj1, respectively. A two-fold increase
in applied current resulted in an approximately proportional
flux enhancement; however, Cyt c flux at 0.3 and 0.5 mA.cmj2
was not significantly different (Student t test, p < 0.05). From
Eq. 1, it is clear that the flux due to electromigration, JEM,
should increase with the applied current and this is the case for
several small molecules and some peptides, both in vitro and
in vivo (24–27). It has been suggested that at high current
densities, the iontophoretic response saturates and once a lim-
iting transport number is achieved, further increase in cur-
rent has no effect (28). Similarly, the cumulative permeation
of Cyt c at 0.3 and 0.5 mA.cmj2 was greater than that at
0.15 mA.cmj2. Figure 3 shows the amounts of Cyt c extrac-
ted from the skin after completion of the permeation ex-
periments. Although greater amounts of protein were
recovered from the skin samples used in the experiments at
0.3 mA.cmj2 (2,060.82 T 367.53 mg.cmj2) than at 0.5 mA.cmj2
(951.55 T 201.08 mg.cmj2); the sum of the amounts extracted
and permeated at the two current densities was not statistically
different.
Co-iontophoresis of ACE enabled the estimation of the
contributions of EM, EO and the calculation of an elec-
troosmotic inhibition factor (IF) (Table I). Control values
for ACE flux in the absence of Cyt c were determined
independently with applied current densities of 0.15, 0.3
or 0.5 mA.cmj2. Calculation of the EO contribution and
subtraction from the total flux showed that EM was the
dominant mechanism, accounting for õ90% of total Cyt c
delivery. A two-fold increase (0.15–0.3 mA.cmj2) in current
produced an approximately proportional increase in the EM
and EO contributions. Inhibition of ACE transport, caused
by reduction of convective solvent flow was only noticeable
at the highest current density (0.5 mA.cmj2), with an IF õ5;
however, this did not have a significant impact on Cyt c
transport since EM was by far the dominant transport
mechanism (Fig. 4). Moreover, although significant amounts
of Cyt c were extracted from the skin following iontophoresis
at 0.3 mA.cmj2, there was no concomitant effect on ACE
transport and hence convective solvent flow (as evidenced by
IF õ1, Table I). Thus, Cyt c accumulation in the membrane
at 0.3 mA.cmj2 was not in itself a sufficient condition for
significant EO inhibition; this may point to Cyt c aggregation
or to the presence of intermolecular interactions that do not
involve the fixed negative charges responsible for skin
permselectivity.
The effect of concentration on the iontophoretic transport
of Cyt c was examined in the second series of experiments.
Figure 5 shows that increasing the donor concentration from
0.35 to 0.7 mM Cyt c, in the absence of competing ions,
affected neither the cumulative permeation (594.0T 257.4 and
923.0T 496.1 mg.cmj2, respectively; t-test, p < 0.05) nor the flux
(Jtot = 182.8T 56.8 and 265.2T 149.1 mg.cm
j2.hj1, respectively;
t-test, p < 0.05). Similarly, ACE transport was not affected by
the two-fold difference in donor concentration and the
solvent permeability coefficient, VW, was effectively
unchanged ((27.9 T 19.0) and (18.4 T 10.8) 10j4cm.hj1
respectively) at the two concentrations. At the lower
concentration, EM was again the dominant transport
mechanism governing the iontophoretic transfer of Cyt c,
accounting for >90% of total flux; thus, there was no change
in the relative contributions of EM and EO to overall elec-
Fig. 2. a Cumulative amounts permeated and steady-state fluxes
(Jtot) of Cyt c across porcine skin during 8 h of transdermal
iontophoresis at 0.15, 0.3 and 0.5 mA.cmj2. (MeanTSD) (n Q 5) and
b Cumulative Cyt c permeation as a function of time during 8 h
iontophoresis at 0.5 mA.cmj2. (MeanTSD) (n = 12).
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trotransport. (Student_s t-test, p < 0.05). Under the experi-
mental conditions used, Cyt c was the sole cation in the
anodal formulation; the majority of the charge transfer was
due to Clj ions moving from the receiver compartment
towards the anode. The electrodiffusion model developed by
Kasting and Keister (28) suggests that, in the absence of
competing cations, iontophoretic flux is independent of
concentration and dependent only on the ratio of diffusivities
(or mobilities) of the cation and the main counterion (usually
Clj) arriving from beneath the skin.
The addition of buffer or an increase in the ionic strength
of the formulation by the addition of background electrolyte
increases competition between charge carriers and generally
decreases iontophoretic drug flux (29–31). The effect of Na+
on the iontophoretic transport of Cyt c (0.7 mM) was
confirmed by formulating the protein in PBS (pH 8.2). The
estimated flux and the transport efficiency as a function of
experimental conditions are shown in Fig. 6. The presence of
õ170 mM Na+ resulted in a 3.9-fold decrease in Jtot
(67.5 T 15.7 mg.cmj2.hj1) which was entirely due to a
decrease in the EM contribution to Cyt c electrotransport.
Calculation of the Cyt c transport number for the two
experimental conditions showed that inclusion of Na+ (at
>200-fold excess as compared to the protein) caused Cyt c
transport efficiency to decrease from 0.048 to 0.010%.
Although the presence of competing ions resulted in a
significant decrease in Cyt c delivery, it did not impact on
EO flow.
DISCUSSION
Electric Mobility Governs Cyt c Electrotransport
The relative contributions of EM and EO (Table I) to
Cyt c electrotransport across the skin show that EM
accounted for õ90% of total delivery despite the molecular
weight of the protein; providing clear evidence that EO does
not per se govern peptide or protein iontophoretic transport
rates (27). The dominant transport mechanism will depend
on the physicochemical properties of the macromolecule, in
particular, its electric mobility. Figure 7 shows the normal-
ized steady state electromigratory flux (JnormEM ) of lidocaine,
propranolol, quinine and a series of lysine- and tyrosine-
containing dipeptides as a function of electrophoretic mobil-
ity (adapted from (18)). Inclusion of the corresponding
normalized flux for Cyt c using the same current density
and similar conditions (0.5 mA.cmj2, 0.7 mM, PBS pH 8.2)
and assuming a mobility of 4 10j5 cm2.Vj1.sj1 (32) shows
that despite its much greater MW, Cyt c electromigration
displays the same correlation with its electrophoretic mobility
(JnormEM ¼ 92:76ui þ 0:0031 , r 2 = 0.97).
High molecular weight peptides and small proteins with
multiple exposed charged amino acid side chains or available
hydrophobic surfaces may interact strongly with structures in
Table I. Iontophoretic Transport Kinetics of Horse Heart Cytochrome C and the Relative Contributions of Electromigration and
Electroosmosis
I (mA cmj2) Jtot (mg cm
j2 hj1) JEM (mg cm
j2 hj1) JEO (mg cm
j2 hj1) 104VW, Cyt c (cm h
j1)
104VW , control
(cm hj1) IF
0.15 90.91 T 45.07 82.00 8.91 8.61 T 4.91 16.61 T 7.45 1.93 T 1.40
0.30 157.77 T 140.13 137.93 19.84 20.94 T 7.92 21.40 T 2.73 1.02 T 0.47
0.50 265.15 T 149.05 248.71 16.44 18.41 T 10.81 90.72 T 29.34 4.93 T 3.08
(nQ 4)
I: Current density, JEM: Electromigration contribution, JEO: Electroosmotic contribution, Jtot: Total steady-state flux, VW,Cyt c: solvent
permeability coefficient in the presence of Cyt c, VW, control: solvent permeability coefficient, IF: Inhibition factor (calculated according to Eq. 3).
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the transport pathway, either through electrostatic or van der
Waals_ type interactions. If these associations are accompa-
nied by neutralization of the fixed negative charges in the
skin, this will result in reduced convective flow. These
interactions with the biological transport pathway will also
reduce the reliability of electrophoretic mobility as a
predictor for peptide or protein electrotransport. Increasing
current density causes more protein to be transported into
the skin and increases the likelihood of interaction: for Cyt c,
inhibition of skin permselectivity was only significant at a
current density of 0.5 mA.cmj2. However, since EM was by
far the dominant transport mechanism it had negligible
impact on total flux.
Feasibility of Delivering Small Proteins by Transdermal
Iontophoresis
Comparison of our results with those of BProtein X^ (13)
is difficult, given the lack of experimental details; however,
assuming similar protein concentrations in the respective
formulations (and the presence of competing ions), then the
current-normalized fluxes are similar (õ150 mg.mA.hj1 for
BProtein X^ and õ135 mg.mA.hj1 for Cyt c in the present
study—0.7 mM, 0.5 mA.cmj2, PBS pH 8.2).
Laser scanning confocal microscopy studies using FITC-
labelled poly-L-lysines with molecular weights of 4, 7 and
26 kDa showed that although iontophoresis (0.5 mA.cmj2 at
0.05 mM polypeptide) enhanced delivery of the 4 kDa
derivative it had little or no effect on the transport of the
larger species; after 8 h iontophoresis at 0.5 mA.cmj2,
cumulative permeation of the 4 and 7 kDa poly-L-lysines
was 3.84T 1.48 and 0.44T 0.12 mg, respectively (12). Iontophoresis
of 2.7, 8.2 and 20 kDa poly-L-lysines (0.5 mA.cmj2 and 3.7, 1.2
and 0.5 mM, respectively) decreased skin permselectivity as
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measured by mannitol flux (by up to 30-fold in the case of the
20 kDa derivative (33)): the pronounced EO inhibition
suggesting the presence of the polypeptide in the transport
pathway. These poly-L-lysine results are very different to those
observed with Cyt c both in terms of cumulative protein
delivery (784.52T 421.64 mg after 8 h at 0.5 mA.cmj2) and the
effect on convective solvent flow (only a õ5-fold decrease in
ACE transport under the same conditions). Furthermore, for
comparison, PL83, a poly-L-lysine containing 83 Lys residues,
with a molecular weight of õ12.5 kDa, is reported to have an
electrical mobility of 16 10j5 cm2.Vj1.sj1 (34), which is four
times greater than that of Cyt c; therefore, why does the latter
show superior iontophoretic transport kinetics?
The poly-L-lysine experiments were conducted using
hairless mouse skin (HMS) whereas the iontophoretic transport
of Cyt c was investigated across porcine ear skin. The nature of
the membrane can have a significant impact on iontophoretic
drug transport rates. For example, although the variation of the
current-normalized convective solvent flow across both HMS
and porcine ear skin (PES) as a function of propranolol
concentration, as reported by mannitol flux, is similar (Fig. 8a),
propranolol transport kinetics are completely different (Fig. 8b)
(3,35,36). Thus, although increasing propranolol concentra-
tion in the formulation has a similar effect on skin permse-
lectivity in both membranes, the presence of drug–drug or
drug-pathway interactions causes current-normalized pro-
pranolol flux across HMS to decrease sharply after reaching
a maximum at 0.4 mM. By analogy, poly-L-lysines may have
a greater propensity to bind to structures along the transport
route or to self-aggregate during iontophoresis across HMS
than is the case for Cyt c in PES.
Cyt c and the poly-L-lysines also have very different
structures and solution conformations. Under physiological
conditions, poly-L-lysine has a dynamic random coil structure
in solution; in contrast, Cyt c possesses a compact globular
structure (2.5 2.5 3.7 nm, (37)) with a well-defined three-
dimensional conformation containing three major and two
minor helices separated by strands with more random
structure, folded around a heme group (19) (Fig. 1). A 20 kDa
poly-L-lysine contains õ130 lysine residues in a polypeptide
chain with a random coil structure. The Lys side-chains will be
extensively exposed to the solution so that the side chain
(-NH2 group can interact with anions or form hydrogen-
bonds with surrounding water molecules—these groups will
also be predisposed to interacting with accessible sites of
negative charge density present in the iontophoretic trans-
port pathway. Although Cyt c is rich in Arg and Lys residues
(õ21 residues), that are also found at the protein surface,
solvent-accessible and whose side-chains show considerable
flexibility (Fig. 1b and d), the more rigid three-dimensional
structure of the protein backbone restricts the number of
possible side-chain-membrane interactions. Furthermore, the
presence of surface negative charges (due to Asp and Glu)
may also hinder interaction with negative sites within the
membrane (Fig. 1a and c). Thus, Cyt c would have a lower
propensity to interact with the membrane and its electro-
transport less likely to modulate skin permselectivity.
With respect to the feasibility of delivering small proteins
through the proposed transport pathways in the skin, analysis
of the results from streaming potential measurements using
excised human cadaver abdominal skin, using a capillary pore
model, suggested the presence of nanopores with a Gaussian
size distribution and a mean radius on the order of õ20 nm
(38). The pore diameter would be sufficient to enable passage
of a small globular protein such as Cyt c. More recently,
scanning electrochemical microscopy (SECM) studies into
the electroosmotic transport of acetaminophen across full-
thickness human cadaver skin demonstrated that electroos-
motic phenomena occurred in pores, tentatively identified as
skin appendageal structures, much larger than nanopores
(39). Conversion of the SECM tip current to a concentration
followed by fitting to an appropriate mathematical model,
enabled estimation of the pore radius (õ35 mm); obviously,
protein transport through these appendageal structures
would be entirely feasible. In contrast, earlier studies with
HMS suggested non-appendageal pore radii of 2.7, 1.35 and
0.675 nm for negative, neutral and positive pores, respective-
ly (40). Similarly, a hydrodynamic model developed using rat
skin suggested that the pore diameter was õ3.6 nm (41). For
these two animal models, the passage of Cyt c through these
narrower, non-appendageal channels would probably be
hindered—these observations may also partly explain the
poly-L-lysine transport results (12,35).
CONCLUSIONS
These results demonstrate the feasibility of delivering
significant amounts of Cyt c, a small, highly charged protein,
non-invasively across intact skin (õ0.9 mg.cmj2 over an 8 h
period). They also show that Cyt c electrotransport was
governed by EM (õ90%) and not EO. Furthermore, neither
Cyt c permeation nor its accumulation in the skin caused EO
inhibition at current densities lower than 0.5 mA.cmj2
(indeed, its occurrence at this current density had negligible
effect on transport kinetics). Thus, a macromolecule with
molecular weight exceeding 12 kDa, possessing a suitable
charge:MW ratio (and hence, electric mobility) and the
appropriate three-dimensional structure can be delivered
non-invasively by transdermal iontophoresis. Globular
proteins with a compact tertiary structure may be better
candidates than highly charged polypeptides with extended
random coil structures since the latter may be more prone to
interaction with the transport pathway (they may also be
more susceptible to enzymatic hydrolysis). Future studies will
build upon the findings with this model protein and apply the
same principles to the non-invasive delivery of therapeutic
proteins across the skin.
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